1. Home
  2. ORA vs KRYS Comparison

ORA vs KRYS Comparison

Compare ORA & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORA
  • KRYS
  • Stock Information
  • Founded
  • ORA 1965
  • KRYS 2015
  • Country
  • ORA United States
  • KRYS United States
  • Employees
  • ORA N/A
  • KRYS N/A
  • Industry
  • ORA Electric Utilities: Central
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ORA Utilities
  • KRYS Health Care
  • Exchange
  • ORA Nasdaq
  • KRYS Nasdaq
  • Market Cap
  • ORA 4.6B
  • KRYS 3.8B
  • IPO Year
  • ORA 2004
  • KRYS 2017
  • Fundamental
  • Price
  • ORA $90.39
  • KRYS $153.25
  • Analyst Decision
  • ORA Buy
  • KRYS Strong Buy
  • Analyst Count
  • ORA 7
  • KRYS 11
  • Target Price
  • ORA $86.43
  • KRYS $204.27
  • AVG Volume (30 Days)
  • ORA 528.6K
  • KRYS 281.4K
  • Earning Date
  • ORA 08-06-2025
  • KRYS 08-04-2025
  • Dividend Yield
  • ORA 0.53%
  • KRYS N/A
  • EPS Growth
  • ORA N/A
  • KRYS 109.01
  • EPS
  • ORA 2.06
  • KRYS 4.16
  • Revenue
  • ORA $885,250,000.00
  • KRYS $333,448,000.00
  • Revenue This Year
  • ORA $9.65
  • KRYS $41.45
  • Revenue Next Year
  • ORA $14.25
  • KRYS $49.05
  • P/E Ratio
  • ORA $43.87
  • KRYS $36.90
  • Revenue Growth
  • ORA 1.95
  • KRYS 247.53
  • 52 Week Low
  • ORA $61.58
  • KRYS $122.80
  • 52 Week High
  • ORA $91.81
  • KRYS $219.34
  • Technical
  • Relative Strength Index (RSI)
  • ORA 71.27
  • KRYS 63.94
  • Support Level
  • ORA $85.98
  • KRYS $146.35
  • Resistance Level
  • ORA $90.85
  • KRYS $153.74
  • Average True Range (ATR)
  • ORA 1.46
  • KRYS 4.36
  • MACD
  • ORA -0.05
  • KRYS 0.54
  • Stochastic Oscillator
  • ORA 77.63
  • KRYS 93.23

About ORA Ormat Technologies Inc.

Ormat Technologies Inc is engaged in the geothermal and recovered energy power business. It is engaged in three business segments: Electricity Segment. where the company develops, builds, owns and operates geothermal, solar PV and recovered energy-based power plants in the United States and geothermal power plants in other countries and sell the electricity generated. Product Segment includes designing, manufacturing and selling equipment for geothermal and recovered energy-based electricity generation and providing services relating to the engineering, procurement and construction of geothermal and recovered energy-based power plants. Energy Storage Segment includes owning and operating grid-connected which provide capacity, energy and ancillary services directly to the electric grid.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: